This episode of "This Week in Virology" features Dr. Daniel Griffin's clinical update, which begins by addressing the political turmoil at the CDC, including the firing of its director and subsequent resignations, described as a "weaponization of public health." The discussion then moves to key infectious disease updates: a continuing Legionnaire's disease outbreak in Harlem, the FDA's suspension of the live attenuated Chikungunya vaccine (Ixchiq) due to a fatal case of encephalitis, and the first identified US human case of New World screwworm in a traveler from El Salvador.
A significant portion of the update is dedicated to respiratory viruses. Dr. Griffin provides the latest statistics on the US measles epidemic, the final influenza pediatric death toll for the past season, and confirms an ongoing COVID-19 surge based on wastewater data. The central focus becomes the drastic shift in US COVID-19 vaccine policy. The FDA has issued new, restrictive approvals for the updated Pfizer, Moderna, and Novavax vaccines, limiting access for healthy individuals under 65 to those with specific risk factors, a move criticized as political and not science-based. This policy is contrasted with the American College of Obstetricians and Gynecologists' strong, unchanged recommendation for COVID-19 vaccination during pregnancy. The segment concludes with a discussion on the importance of vaccination for preventing long COVID and a call to action to support science against political interference.
Navigating Public Health Challenges: A Clinical Update on Infectious Diseases and Vaccine Policies
2:03 Assault on Public Health: Dr. Griffin discusses the recent firing of the CDC director, followed by the resignation of three other senior leaders. This is framed as a political move to install leadership aligned with an anti-vaccine, anti-science agenda and an effort to "weaponize public health."
5:00 Legionnaire's Outbreak Update: As of the recording, the Legionnaire's disease outbreak in Harlem has reached 114 confirmed cases and 7 deaths. Dr. Griffin explains the investigation process, highlighting the difference between rapid PCR tests (which detect bacterial DNA) and slower culture tests (which confirm live, infectious bacteria) used to identify the source in cooling towers.
8:24 Chikungunya Vaccine Suspended: The FDA has suspended the license for Ixchiq, the live attenuated Chikungunya vaccine, following a death from encephalitis directly attributed to the vaccine strain and over 20 other serious adverse events. An alternative virus-like particle (VLP) vaccine remains an option.
10:08 First U.S. Case of New World Screwworm: A rare, travel-related human case of New World screwworm myiasis (a parasitic infestation of fly larvae) was identified in Maryland. The parasite, which eats the living tissue of warm-blooded animals, poses a significant threat to livestock and the food supply.
15:45 Measles Epidemic Concerns: The U.S. has recorded 1,048 measles cases across 43 jurisdictions. There is significant concern about what will happen as children, many of whom are unvaccinated, return to school.
17:17 Influenza Season Recap: The final tally for the 2024-2025 flu season shows 275 influenza-associated pediatric deaths, the highest number in a non-pandemic season since it became reportable. Approximately 90% of these children were unvaccinated.
21:04 Vaccine Recommendations in Pregnancy: The American College of Obstetricians and Gynecologists (ACOG) has reaffirmed its strong recommendation for pregnant individuals to receive the COVID-19, flu, and RSV vaccines, despite the CDC removing its recommendation for the COVID-19 vaccine in this group.
23:19 Restrictive COVID-19 Vaccine Access: The FDA has approved the updated (LP.8.1) COVID-19 vaccines from Pfizer, Moderna, and Novavax with new restrictions. Healthy individuals under the age of 65 will now require a consultation with a physician and must have at least one underlying risk factor to be eligible for the vaccine. Access remains unrestricted for those 65 and older.
29:10 Policy Criticized as Unscientific: This new policy is condemned as a non-evidence-based decision driven by politics. It severely limits access to safe and effective vaccines for a large portion of the population who may wish to protect themselves from infection and long COVID.
31:41 The Risk of Long COVID: The new vaccine restrictions are particularly concerning for younger, healthy individuals who want to reduce their risk of developing debilitating long COVID, a severe outcome that anti-vaccine proponents often ignore.